Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 14.39
(-0.41%)
CNY 14.39
(-0.41%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.85 Billion CNY | 37.14% |
| 2022 | 7.91 Billion CNY | 12.4% |
| 2021 | 7.04 Billion CNY | 40.76% |
| 2020 | 5 Billion CNY | 7.1% |
| 2019 | 4.67 Billion CNY | 41.31% |
| 2018 | 3.3 Billion CNY | 5.17% |
| 2017 | 3.14 Billion CNY | 4.79% |
| 2016 | 2.99 Billion CNY | -10.09% |
| 2015 | 3.33 Billion CNY | 51.04% |
| 2014 | 2.2 Billion CNY | 42.37% |
| 2013 | 1.55 Billion CNY | 15.46% |
| 2012 | 1.34 Billion CNY | 20.63% |
| 2011 | 1.11 Billion CNY | 30.1% |
| 2010 | 855.96 Million CNY | 34.94% |
| 2009 | 634.32 Million CNY | 8.12% |
| 2008 | 586.68 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 12.24 Billion CNY | 12.88% |
| 2024 Q2 | 11.12 Billion CNY | -9.21% |
| 2024 Q3 | 11 Billion CNY | -1.01% |
| 2023 Q2 | 11.33 Billion CNY | 3.48% |
| 2023 FY | 10.85 Billion CNY | 37.14% |
| 2023 Q1 | 10.95 Billion CNY | 38.44% |
| 2023 Q3 | 11.29 Billion CNY | -0.36% |
| 2023 Q4 | 10.85 Billion CNY | -3.92% |
| 2022 FY | 7.91 Billion CNY | 12.4% |
| 2022 Q4 | 7.91 Billion CNY | 0.94% |
| 2022 Q3 | 7.83 Billion CNY | -1.11% |
| 2022 Q2 | 7.92 Billion CNY | 5.07% |
| 2022 Q1 | 7.54 Billion CNY | 7.18% |
| 2021 Q1 | 5.68 Billion CNY | 13.67% |
| 2021 Q4 | 7.04 Billion CNY | 9.11% |
| 2021 Q2 | 6.16 Billion CNY | 8.51% |
| 2021 Q3 | 6.45 Billion CNY | 4.59% |
| 2021 FY | 7.04 Billion CNY | 40.76% |
| 2020 Q2 | 5.06 Billion CNY | 1.36% |
| 2020 FY | 5 Billion CNY | 7.1% |
| 2020 Q3 | 4.86 Billion CNY | -3.94% |
| 2020 Q4 | 5 Billion CNY | 2.83% |
| 2020 Q1 | 4.99 Billion CNY | 6.96% |
| 2019 FY | 4.67 Billion CNY | 41.31% |
| 2019 Q2 | 3.22 Billion CNY | -3.46% |
| 2019 Q3 | 3.6 Billion CNY | 11.88% |
| 2019 Q1 | 3.33 Billion CNY | 1.04% |
| 2019 Q4 | 4.67 Billion CNY | 29.49% |
| 2018 Q1 | 3.37 Billion CNY | 7.53% |
| 2018 FY | 3.3 Billion CNY | 5.17% |
| 2018 Q4 | 3.3 Billion CNY | 3.61% |
| 2018 Q3 | 3.18 Billion CNY | -0.89% |
| 2018 Q2 | 3.21 Billion CNY | -4.76% |
| 2017 Q3 | 3.15 Billion CNY | 1.36% |
| 2017 Q4 | 3.14 Billion CNY | -0.47% |
| 2017 FY | 3.14 Billion CNY | 4.79% |
| 2017 Q1 | 3.11 Billion CNY | 3.84% |
| 2017 Q2 | 3.11 Billion CNY | 0.03% |
| 2016 Q1 | 3.31 Billion CNY | -0.66% |
| 2016 Q4 | 2.99 Billion CNY | -0.69% |
| 2016 Q3 | 3.01 Billion CNY | 1.63% |
| 2016 Q2 | 2.97 Billion CNY | -10.32% |
| 2016 FY | 2.99 Billion CNY | -10.09% |
| 2015 Q4 | 3.33 Billion CNY | 21.71% |
| 2015 Q3 | 2.74 Billion CNY | -2.12% |
| 2015 Q2 | 2.79 Billion CNY | 28.85% |
| 2015 Q1 | 2.17 Billion CNY | -1.61% |
| 2015 FY | 3.33 Billion CNY | 51.04% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q4 | 2.2 Billion CNY | -16.99% |
| 2014 Q2 | 1.79 Billion CNY | 0.0% |
| 2014 Q3 | 2.66 Billion CNY | 47.87% |
| 2014 FY | 2.2 Billion CNY | 42.37% |
| 2013 Q4 | 1.55 Billion CNY | 0.0% |
| 2013 FY | 1.55 Billion CNY | 15.46% |
| 2012 FY | 1.34 Billion CNY | 20.63% |
| 2011 FY | 1.11 Billion CNY | 30.1% |
| 2010 FY | 855.96 Million CNY | 34.94% |
| 2009 FY | 634.32 Million CNY | 8.12% |
| 2008 FY | 586.68 Million CNY | 0.0% |